All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the GvHD Hub spoke to Erik Thiele Orberg, Technical University of Munich, Munich, DE. We asked, How can we use microbial-derived metabolites to prevent GvHD?
How can we use microbial-derived metabolites to prevent GvHD?
Microbial-derived metabolites are small, easily synthesized molecules that may offer the same benefits as fecal microbiota transplant, without concerns for transmitting infectious diseases, like COVID-19. Orberg envisions that metabolites could be administered prophylactically to patients undergoing stem cell transplantation.
Is the composition of gut fungal microbiota a predictor of mortality after allo-transplantation?
The GvHD Hub are proud to present expert interviews directly from the 61st American Society of Hematology (ASH) meeting in Orlando, US. This interview...
EBMT GvHD Summit 2019 | Treatment of acute GvHD based on the EBMT–ELN working group recommendations
Corticosteroids are the accepted first-line treatment for aGvHD, however other treatments are sought due to steroid resistance or steroid dependence...
Subscribe to get the best content related to GvHD delivered to your inbox